Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Persistent mixed cryoglobulinaemia vasculitis despite hepatitis C virus eradication after interferon-free antiviral therapy.

× No keyword cloud information.

19 in total

1. KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.

Authors:
Journal: Kidney Int Suppl (2011) Date: 2018-09-19

Review 2. Impact of Direct Acting Antiviral Agent Therapy upon Extrahepatic Manifestations of Hepatitis C Virus Infection.

Authors: Arpan Mohanty; Sarah Salameh; Adeel A Butt
Journal: Curr HIV/AIDS Rep Date: 2019-10 Impact factor: 5.071

3. Direct-Acting Antivirals and Mixed Cryoglobulinemia Vasculitis: Long-Term Outcome of Patients Achieving HCV Eradication.

Authors: Salvatore Sollima; Laura Milazzo; Spinello Antinori; Massimo Galli
Journal: Am J Gastroenterol Date: 2017-11 Impact factor: 10.864

4. Efficacy and safety of Glecaprevir/Pibrentasvir in the treatment of mixed cryo-globulinemia due to chronic hepatitis C cirrhosis in a patient with chronic kidney disease.

Authors: N Papadopoulos; S Flouda; E Sveroni; M C Tatarida Palla; V German
Journal: Hippokratia Date: 2019 Jan-Mar Impact factor: 0.471

Review 5. Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection.

Authors: Iman Ibrahim Salama; Hala M Raslan; Ghada A Abdel-Latif; Somaia I Salama; Samia M Sami; Fatma A Shaaban; Aida M Abdelmohsen; Walaa A Fouad
Journal: World J Hepatol Date: 2022-06-27

Review 6. Advances in HCV and Cryoglobulinemic Vasculitis in the Era of DAAs: Are We at the End of the Road?

Authors: Chalermrat Bunchorntavakul; Robert Mitrani; K Rajender Reddy
Journal: J Clin Exp Hepatol Date: 2017-12-07

Review 7. The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents.

Authors: Dario Roccatello; Savino Sciascia; Daniela Rossi; Laura Solfietti; Roberta Fenoglio; Elisa Menegatti; Simone Baldovino
Journal: Oncotarget Date: 2017-06-20

8. Persistent Hepatitis C Virus-Associated Cryoglobulinemic Glomerulonephritis in Patients Successfully Treated With Direct-Acting Antiviral Therapy.

Authors: Dominick Santoriello; Nanda K Pullela; Kalpana A Uday; Shawn Dhupar; Jai Radhakrishnan; Vivette D D'Agati; Glen S Markowitz
Journal: Kidney Int Rep Date: 2018-04-10

9. Spectrum of Kidney Diseases in Patients With Hepatitis C Virus Infection.

Authors: Shunhua Guo; Meghan E Kapp; Diego M Beltran; Cesar Y Cardona; Dawn J Caster; Ronald R Reichel; Agnes B Fogo
Journal: Am J Clin Pathol Date: 2021-08-04 Impact factor: 5.400

10. Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience.

Authors: Gianfranco Lauletta; Sabino Russi; Fabio Pavone; Angelo Vacca; Franco Dammacco
Journal: Arthritis Res Ther Date: 2017-04-08 Impact factor: 5.156